Neurology Book

//fpnotebook.com/

Akathisia

Aka: Akathisia, Medication-Induced Acute Akathisia
  1. See Also
    1. Extrapyramidal Side Effect
    2. Movement Disorder
    3. Serotonin Syndrome
  2. Definitions
    1. Akathisia
      1. Motor restlessness or psychomotor aggitation typically as a medication-related Extrapyramidal Side Effect
      2. May present as inability to sit still, pacing or wringing hands
  3. Pathophysiology
    1. Decreased Dopaminergic activity in the mesocortical pathway
      1. Mesocortical Pathway originates in the ventral tegmental area
      2. Mesocortical Pathway projects to the limbic system and prefrontal cortex
    2. Mesocortical pathway typically inhibits motor function
      1. When this pathway is inihibited, unwanted involuntary movement occurs
    3. Other effects
      1. Decreased Dopaminergic activity in ventral tegmental area may increases Serotonin and Norepinephrine activity
  4. Symptoms
    1. Tense and ucomfortable Sensation
    2. Timing
      1. Onset may be abrupt with rapid infusion of IV medications (e.g. Compazine, metoclopramide)
  5. Signs
    1. Leg fidgety movement
    2. Pacing
    3. Inability to sit still
    4. Rocking from foot to foot, shifting weight while standing
  6. Causes: Medication-Induced Acute Akathisia
    1. Antipsychotics
    2. Antidepressants
      1. Selective Serotonin Reuptake Inhibitors
      2. Buspirone
    3. Antiemetics
      1. Compazine
      2. Metoclopramide (Reglan)
    4. Antihypertensives
      1. Reserpine
      2. Alpha-Methyldopa
      3. Diltiazem
    5. Antibiotics
      1. Azithromycin
    6. Neurologic Agents
      1. Pregabalin (Lyrica)
  7. Differential Diagnosis
    1. Mania
    2. Anxiety Disorder
    3. Substance Abuse (e.g. MethamphetamineIntoxication)
    4. Serotonin Syndrome
    5. Restless Leg Syndrome
    6. Drug Withdrawal
  8. Management
    1. Reduce medication dose or switch to alternative medication
    2. Acute symptomatic management
      1. Beta Blockers
        1. Propranolol 40-80 mg orally daily
      2. Serotonin Antagonists (5HT-2A)
        1. Mirtazapine 15 mg orally daily
        2. Cyproheptadine (Periactin) 8-16 mg orally daily
      3. Benzodiazepines
        1. Clonazepam 0.5 to 1 mg daily to twice daily
        2. Diazepam 5-15 mg orally daily
      4. Anticholinergics
        1. Benztropine (Cogentin) 1-4 mg orally daily
      5. Other agents
        1. Amantadine 100 mg orally daily
        2. Clonidine 0.1 mg orally daily to twice daily
  9. Prevention
    1. Infuse Compazine or Metoclopramide over 30 minutes in a bag (e.g. D5W) instead of a bolus over minutes
  10. References
    1. Tachere (2017) Aust Fam Physician 46(5):296-8 [PubMed]

Neuroleptic-induced acute akathisia (C0236835)

Concepts Disease or Syndrome (T047)
ICD10 G25.71
SnomedCT 22719003
DSM4 333.99
English Neuroleptic-Induced Acute Akathisia, acute neuroleptic-induced akathisia (diagnosis), acute neuroleptic-induced akathisia, Neuroleptic induced acute akathisia, Neuroleptic induced akathisia, acute, Neuroleptic-induced acute akathisia, Neuroleptic-induced acute akathisia (disorder)
Spanish acatisia aguda inducida por neurolépticos (trastorno), acatisia aguda inducida por neurolépticos
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree